Mercator Medical (WAR:MRC) Other Long Term Assets: zł Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MRC Mercator Medical SA WAR:MRC
58 GF Score
Price zł56.90
GF Value zł52.24
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Mercator Medical Other Long Term Assets?

Mercator Medical WAR:MRC -0.52% 58 Other Long Term Assets is zł Mil as of Jun. 2026. GuruFocus rates WAR:MRC with a GF Score™ of 58/100 and a GF Value™ of zł52.24 (Fairly Valued). The stock has 6 warning signs investors should review.

Mercator Medical's other long-term assets for the quarter that ended in Jun. 2026 was zł Mil.

Mercator Medical's quarterly other long-term assets increased from Dec. 2025 (zł127.3 Mil) to Mar. 2026 (zł129.0 Mil) but then stayed the same from Mar. 2026 (zł129.0 Mil) to Jun. 2026 (zł Mil).

Mercator Medical's annual other long-term assets declined from Dec. 2023 (zł84.3 Mil) to Dec. 2024 (zł46.8 Mil) but then increased from Dec. 2024 (zł46.8 Mil) to Dec. 2025 (zł127.3 Mil).

Mercator Medical Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Mercator Medical's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercator Medical Other Long Term Assets Chart

Mercator Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.67 59.30 84.30 46.75 127.26

Mercator Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.02 67.23 127.26 129.01 -
WAR:MRC
58GF Score
Mercator Medical SA WAR:MRC
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercator Medical Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of zł Mil mean?
Mercator Medical (WAR:MRC) has a Other Long Term Assets of zł Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Mercator Medical and its competitors.
Is Mercator Medical's Other Long Term Assets too high?
Mercator Medical's current Other Long Term Assets is zł Mil. Overall, Mercator Medical has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's Other Long Term Assets compare to ISRG and BDX?
Mercator Medical's Other Long Term Assets of zł Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Medical Devices & Instruments company?
A good Other Long Term Assets depends on the Medical Devices & Instruments industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Mercator Medical and its competitors. Mercator Medical's current Other Long Term Assets is zł Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (WAR:MRC) is currently considered Fairly Valued. The stock's GF Value™ is zł52.24, compared to a current price of zł56.90 — trading 8.9% above its estimated fair value. The current Other Long Term Assets is zł Mil. Mercator Medical's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Mercator Medical (WAR:MRC), the current Other Long Term Assets is zł Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (WAR:MRC) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be overvalued. The current stock price of zł56.90 is trading 8.9% above its estimated GF Value™ of zł52.24. GuruFocus considers Mercator Medical to be Fairly Valued.

Key valuation signals for WAR:MRC:

  • Other Long Term Assets: zł Mil
  • GF Value™: zł52.24 vs. price of zł56.90 (8.9% above fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the WAR:MRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mercator Medical Business Description

Other Exchanges MM2:Germany
Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
58GF Score

Get the complete analysis for WAR:MRC

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł56.90
Price
zł52.24
GF Value